China companies try to list in US in test for regulators after clampdown
A handful of companies are seeking to become the first China-headquartered businesses to go public in the US since July, in a test of regulators’ willingness to accept new listings after clampdowns on both sides of the Pacific.
Six China and Hong Kong-based groups filed new or updated documents with the US Securities and Exchange Commission for an initial public offering on the Nasdaq exchange in January. They were followed last week by Meihua International Medical Technologies, a producer of disposable medical devices, which set a target offering price after submitting its initial filing almost six months ago.
总部位于中国内地或香港的六家集团1月向美国证交会(SEC)提交了新文件或更新版文件，申请在纳斯达克(Nasdaq)进行首次公开发行(IPO)。上周, 近六个月前提交初始申请的一次性医疗器械生产商——美华国际医疗科技公司(Meihua International Medical Technologies)紧随其后，设定了目标发行价。
Although each deal is expected to be small in size, lawyers, exchange officials and China experts will be watching them closely for signs that there is still a future for the once-thriving market for Chinese listings.